A simple and sensitive method for measuring tumor-specific T cell cytotoxicity

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Fu, Xinping ^a   Tao, Lihua ^a   Rivera, Armando ^a   Williamson, Shana ^b   Song, Xiao Tong ^c   Ahmed, Nabil ^c   Zhang, Xiaoliu ^a,b  

^a University of Houston   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIREFLY LUCIFERASE; TUMOR ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; LUCIFERASE;

ACCURACY; ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME RELEASE; FEASIBILITY STUDY; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; SENSITIVITY ANALYSIS; SUPERNATANT; TARGET CELL; TUMOR CELL CULTURE; TUMOR CELL DESTRUCTION; ANIMAL; BAGG ALBINO MOUSE; BIOASSAY; CELL SURVIVAL; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; METHODOLOGY; PHYSIOLOGY;

ANIMALS; BIOLOGICAL ASSAY; CELL SURVIVAL; HUMANS; LUCIFERASES; MICE; MICE, INBRED BALB C; RECEPTOR, ERBB-2; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77955651021     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011867     Document Type: Article

References (16)

1. Harty JT, Tvinnereim AR, White DW (2000) CD8+ T cell effector mechanisms in resistance to infection. Annu Rev Immunol 18: 275-308.
2. Nelson DL, Kurman CC, Serbousek DE (2001) 51Cr release assay of antibodydependent cell-mediated cytotoxicity (ADCC). Curr Protoc Immunol Chapter 7: Unit 7 27.
3. Ayres FM, Narita M, Takahashi M, Alldawi L, Liu A, et al. (2003) A comparative study of the JAM test and 51Cr-release assay to assess the cytotoxicity of dendritic cells on hematopoietic tumor cells. Immunol Invest 32: 219-227.
4. Andre ND, Barbosa DS, Munhoz E, Estevao D, Cecchini R, et al. (2004) Measurement of cytotoxic activity in experimental cancer. J Clin Lab Anal 18: 27-30.
5. Hoppner M, Luhm J, Schlenke P, Koritke P, Frohn C (2002) A flow-cytometry based cytotoxicity assay using stained effector cells in combination with native target cells. J Immunol Methods 267: 157-163.
6. van Baalen CA, Kwa D, Verschuren EJ, Reedijk ML, Boon AC, et al. (2005) Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity. J Infect Dis 192: 1183-1190.
7. Chen K, Chen L, Zhao P, Marrero L, Keoshkerian E, et al. (2005) FL-CTL assay: fluorolysometric determination of cell-mediated cytotoxicity using green fluorescent protein and red fluorescent protein expressing target cells. J Immunol Methods 300: 100-114.
8. Nakazawa Y, Huye LE, Dotti G, Foster AE, Vera JF, et al. (2009) Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytes. J Immunother 32: 826-836.
9. Aslakson CJ, Miller FR (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52: 1399-1405.
10. Wilson MH, Coates CJ, George AL, Jr. (2007) PiggyBac transposon-mediated gene transfer in human cells. Mol Ther 15: 139-145.
11. Ahmed N, Ratnayake M, Savoldo B, Perlaky L, Dotti G, et al. (2007) Regression of experimental medulloblastoma following transfer of HER2-specific T cells. Cancer Res 67: 5957-5964.
12. Li X, Lobo N, Bauser CA, Fraser MJ, Jr. (2001) The minimum internal and external sequence requirements for transposition of the eukaryotic transformation vector piggyBac. Mol Genet Genomics 266: 190-198.
13. Thompson JF, Hayes LS, Lloyd DB (1991) Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene 103: 171-177.
14. Kurschus FC, Fellows E, Stegmann E, Jenne DE (2008) Granzyme B delivery via perforin is restricted by size, but not by heparan sulfate-dependent endocytosis. Proc Natl Acad Sci U S A 105: 13799-13804.
15. Haynes NM, Trapani JA, Teng MW, Jackson JT, Cerruti L, et al. (2002) Singlechain antigen recognition receptors that costimulate potent rejection of established experimental tumors. Blood 100: 3155-3163.
16. Cohen CJ, Li YF, El-Gamil M, Robbins PF, Rosenberg SA, et al. (2007) Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond. Cancer Res 67: 3898-3903.